← Scroll for more →
Financial Statements — GSK
Balance Sheet
(in billions GBP)| Metric | Q4 2025 | Q4 2024 | Q4 2023 | Q4 2022 | Q4 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 3.40 | 3.87 | 2.94 | 3.72 | 4.27 |
| Inventory | 5.92 | 5.67 | 5.50 | 5.15 | 5.78 |
| Total Current Assets | 17.51 | 17.00 | 18.64 | 20.77 | 18.67 |
| Goodwill | 7.02 | 6.98 | 6.81 | 7.05 | 10.55 |
| Total Non-current Assets | 43.61 | 42.47 | 40.36 | 39.38 | 60.43 |
| Total Assets | 61.12 | 59.46 | 59.01 | 60.15 | 79.10 |
| Total Current Liabilities | 21.39 | 21.70 | 21.07 | 22.81 | 23.67 |
| Total Non-current Liabilities | 23.77 | 24.68 | 25.14 | 27.24 | 34.09 |
| Total Liabilities | 45.16 | 46.38 | 46.21 | 50.05 | 57.76 |
| Retained Earnings | 10.21 | 7.80 | 7.24 | 4.36 | 7.94 |
| Total Stockholder Equity | 15.96 | 13.09 | 12.80 | 10.10 | 21.34 |
← Scroll for more columns →